Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

hameln pharmaceuticals gmbh - dobutamine hydrochloride - solution for infusion - 5 mg/ml

Iżrael - Ingliż - Ministry of Health

raz pharmaceutics ltd, israel - dobutamine as hydrochloride - concentrate for solution for infusion - dobutamine as hydrochloride 12.5 mg/ml - dobutamine - dobutamine is indicated for patients who require a positive inotropic support in the short term treatment of adults with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures, especially when a low cardiac output is associated with raised pulmonary pressure.

Malasja - Ingliż - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

medispec (m) sdn.bhd - dobutamine hydrochloride -

Stati Uniti - Ingliż - NLM (National Library of Medicine)

hikma farmaceutica - dobutamine hydrochloride (unii: 0wr771djxv) (dobutamine - unii:3s12j47372) -

Malta - Ingliż - Medicines Authority

p & d pharmaceuticals limited - dobutamine 12.5 mg/ml - solution for injection

Baħrajn - Ingliż - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

wael pharmacy - dobutamine hydrochloride - sol. fol injection inj. - 250

Filippini - Ingliż - FDA (Food And Drug Administration)

h & b pharma int'l inc - dobutamine (as hydrochloride) - solution for injection iv infusion - 50mg/ml (250mg/5ml)

Filippini - Ingliż - FDA (Food And Drug Administration)

baxter healthcare phils inc - dobutamine hydrochloride 5% dextrose - solution for injection iv - 2mg/ml (200mcg/ml)

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - dobutamine hydrochloride - solution for infusion - 12.5mg/1ml

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - dobutamine hydrochloride - solution for infusion - 12.5mg/1ml